Bill Tracker · West Virginia

HB4626

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Status

Vetoed

2026 Session

IntroducedJan 21, 2026 (done)
PassedMar 12, 2026 (done)
VetoedMar 14, 2026 (failed)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Ryan Browning (Republican)
Type: Clinical Research
Substances: Ibogaine

Official text

Summary (from PoliPsy)

The purpose of this bill is to establish a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the Administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: wvlegislature.gov

Legislative history

April 1, 2026
Vetoed by Governor 4/1/2026 - House Journal
March 14, 2026
Vetoed
March 12, 2026
Enrolled (Passed Both Chambers)
March 9, 2026
Committee Report
February 18, 2026
Referred
February 18, 2026
Committee Report
January 30, 2026
Referred
January 30, 2026
Referred
January 29, 2026
Engrossed (Passed One Chamber)
January 21, 2026
Referred
January 21, 2026
Introduced

Loading bill…